Evidence map›Paper›PMID 33684026›Full record

ArticlePharmaceutical biology2021

Naoxintong accelerates diabetic wound healing by attenuating inflammatory response.

Leyu Fang, Lu Chen, Min Song, Juan He, Lusha Zhang, Chunxiao Li, Qianyi Wang, Wenjie Yang, Wei Sun, Yuze Leng and 4 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Leyu FangState Key Laboratory of Component-based Chinese Medicine, Tianjin, China.
Lu ChenState Key Laboratory of Component-based Chinese Medicine, Tianjin, China.
Min SongState Key Laboratory of Component-based Chinese Medicine, Tianjin, China.
Juan HeBuchang Pharmaceutical Co. Ltd., Xi'an, China.
Lusha ZhangState Key Laboratory of Component-based Chinese Medicine, Tianjin, China.
Chunxiao LiState Key Laboratory of Component-based Chinese Medicine, Tianjin, China.
Qianyi WangState Key Laboratory of Component-based Chinese Medicine, Tianjin, China.
Wenjie YangState Key Laboratory of Component-based Chinese Medicine, Tianjin, China.
Wei SunState Key Laboratory of Component-based Chinese Medicine, Tianjin, China.
Yuze LengState Key Laboratory of Component-based Chinese Medicine, Tianjin, China.
Hong ShiState Key Laboratory of Component-based Chinese Medicine, Tianjin, China.
Shaoxia WangState Key Laboratory of Component-based Chinese Medicine, Tianjin, China.
Xiumei GaoState Key Laboratory of Component-based Chinese Medicine, Tianjin, China.
Hong WangState Key Laboratory of Component-based Chinese Medicine, Tianjin, China.
Tianjin University of Traditional Chinese Medicine · CNBuchang Pharma (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextNaoxintong (NXT), a prescribed traditional Chinese medicine, widely used in cerebrovascular and cardiovascular diseases, could be effective in diabetic wounds.

objectiveThis study evaluates the wound healing activity of NXT by employing an excisional wound splinting model. MATERIALS AND

methodsNXT was dissolved in saline and given daily by gavage. Wounds were induced at the dorsum of non-diabetic (db/+) and diabetic (db/db) mice and treated with saline or 700 mg/kg/d NXT for 16 days. Wound closure was measured every four days. Extracellular matrix (ECM) remodelling, collagen deposition, leukocyte infiltration and expression of Col-3, CK14, CXCL1, CXCL2, MPO, Ly6G, CD68, CCR7, CD206, p-JAK1, p-STAT3 and p-STAT6 was analysed.

resultsNXT significantly accelerated rate of wound closure increased from 70% to 84%, accompanied by up-regulation of collagen deposition and ECM at days 16 post-injury. Moreover, NXT alleviated neutrophil infiltration, accompanied by down-regulation of CXCL1 and CXCL2 mRNA expression. In addition, NXT markedly augmented neutrophil efferocytosis. In diabetic wounds, the levels of M1 marker gene (CCR7) increased, while M2 marker gene (CD206) decreased, demonstrating a pro-inflammatory shift. Application of NXT increased M2 macrophage phenotype in db/db mice. Mechanistically, NXT treatment increased expression level of p-STAT3 and p-STAT6 at days 3 post-injury, indicating NXT mediated macrophages towards M2 phenotype and alleviated inflammation in diabetic wounds by activation of STAT3 and STAT6.

conclusionsOur study provides evidence that NXT accelerates diabetic wound healing by attenuating inflammatory response, which provides an important basis for use of NXT in the treatment of chronic diabetic wound healing.

Indexed as

AnimalsDiabetes Mellitus, ExperimentalDrugs, Chinese HerbalExtracellular MatrixInflammationMacrophagesMaleMiceSTAT3 Transcription FactorSTAT6 Transcription FactorWound HealingDrugs, Chinese HerbalnaoxintongStat3 protein, mouseSTAT3 Transcription FactorStat6 protein, mouseSTAT6 Transcription FactorECM remouldingEfferocytosismacrophage polarization

Identifiers

PMID33684026
PMCPMC7946048
OpenAlexW3135622110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.